Sensei Financial Statements From 2010 to 2026

SNSE Stock

USD 11.62 0.56 5.06%

Sensei Biotherapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sensei Biotherapeutics' valuation are provided below:

Market Capitalization

13.9 M

Earnings Share

(19.14)

There are over one hundred nineteen available fundamental trend indicators for Sensei Biotherapeutics, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Sensei Biotherapeutics' current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

Check Sensei Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sensei Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 3 M, Depreciation And Amortization of 1 M or Interest Expense of 77 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.01. Sensei financial statements analysis is a perfect complement when working with Sensei Biotherapeutics Valuation or Volatility modules.

Build AI portfolio with Sensei Stock

Check out the analysis of Sensei Biotherapeutics Correlation against competitors.

For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

Sensei Biotherapeutics Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

65.3 M

52.2 M

32.2 M

Slightly volatile

Short and Long Term Debt Total

4.8 M

3.5 M

5.2 M

Very volatile

Other Current Liabilities

1.5 M

2.2 M

1.2 M

Slightly volatile

Total Current Liabilities

6.2 M

4.9 M

5.1 M

Slightly volatile

Other Liabilities

127.4 K

134.1 K

658 K

Slightly volatile

Property Plant And Equipment Net

4.2 M

3.9 M

2.1 M

Slightly volatile

Accounts Payable

2.1 M

1.1 M

1.8 M

Slightly volatile

Cash

10.3 M

11.5 M

5.4 M

Slightly volatile

Non Current Assets Total

4.3 M

3.9 M

2.4 M

Slightly volatile

Non Currrent Assets Other

41 K

43.2 K

286.8 K

Slightly volatile

Long Term Debt

484.8 K

510.3 K

2.4 M

Slightly volatile

Cash And Short Term Investments

59.6 M

47.5 M

28.9 M

Slightly volatile

Common Stock Shares Outstanding

27 M

28.9 M

13.7 M

Slightly volatile

Liabilities And Stockholders Equity

65.3 M

52.2 M

32.2 M

Slightly volatile

Non Current Liabilities Total

1.3 M

1.4 M

31.7 M

Slightly volatile

Other Current Assets

648.9 K

683.1 K

893.4 K

Pretty Stable

Total Liabilities

6 M

6.3 M

36.7 M

Slightly volatile

Property Plant And Equipment Gross

5.1 M

5.6 M

2.6 M

Slightly volatile

Short and Long Term Debt

19.4 M

18.5 M

8.3 M

Slightly volatile

Total Current Assets

61 M

48.2 M

29.9 M

Slightly volatile

Non Current Liabilities Other

57.3 K

60.3 K

374.4 K

Slightly volatile

Short Term Debt

2.8 M

2.1 M

2 M

Pretty Stable

Property Plant Equipment

5.6 M

5.3 M

1.9 M

Slightly volatile

Capital Lease Obligations

4.5 M

4.4 M

1.8 M

Slightly volatile

Sensei Biotherapeutics Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

1 M

633.6 K

506.3 K

Slightly volatile

Interest Expense

77 K

81 K

480.5 K

Very volatile

Selling General Administrative

13.1 M

15 M

8.7 M

Slightly volatile

Other Operating Expenses

31.6 M

36.4 M

21.8 M

Slightly volatile

Research Development

18.5 M

21.4 M

13.1 M

Slightly volatile

Cost Of Revenue

619.3 K

633.6 K

326.2 K

Slightly volatile

Total Operating Expenses

31.3 M

35.8 M

21.6 M

Slightly volatile

Reconciled Depreciation

794 K

1.5 M

454.1 K

Slightly volatile

Income Tax Expense

85.5 K

90 K

396.4 K

Very volatile

Selling And Marketing Expenses

80 K

90 K

98.2 K

Slightly volatile

Sensei Biotherapeutics Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Stock Based Compensation

3.6 M

2.3 M

Slightly volatile

Begin Period Cash Flow

10.3 M

15 M

10.2 M

Pretty Stable

Depreciation

790.6 K

1.5 M

452.6 K

Slightly volatile

Other Non Cash Items

1.1 M

1.4 M

876.6 K

Slightly volatile

Capital Expenditures

124.8 K

131.4 K

262.8 K

Slightly volatile

End Period Cash Flow

10.3 M

11.5 M

5.4 M

Slightly volatile

Change To Netincome

3.9 M

6.6 M

3 M

Slightly volatile

Issuance Of Capital Stock

855

900

33.6 M

Pretty Stable

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Capex To Depreciation

0.12

0.13

0.9722

Very volatile

Payables Turnover

0.42

0.4

0.1597

Slightly volatile

Cash Per Share

1.64

1.48

1.4743

Slightly volatile

Days Payables Outstanding

903

951

6 K

Slightly volatile

Income Quality

0.64

0.74

0.7808

Very volatile

Current Ratio

7.62

6.93

5.0017

Slightly volatile

Capex Per Share

0.0064

0.0067

0.0328

Slightly volatile

Interest Debt Per Share

0.17

0.18

4.0265

Slightly volatile

Debt To Assets

0.0926

0.0975

2.162

Slightly volatile

Days Of Payables Outstanding

903

951

6 K

Slightly volatile

Ebt Per Ebit

1.13

1.06

1.0338

Very volatile

Quick Ratio

7.62

6.93

5.0017

Slightly volatile

Net Income Per E B T

0.8

0.9

0.9863

Slightly volatile

Cash Ratio

1.29

1.65

0.9507

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

1.12

1.16

1.0275

Slightly volatile

Debt Ratio

0.0926

0.0975

2.162

Slightly volatile

Sensei Biotherapeutics Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

196.9 M

221.5 M

241.8 M

Slightly volatile

Enterprise Value

192 M

216 M

235.8 M

Slightly volatile

Sensei Fundamental Market Drivers

Sensei Upcoming Events

	26th of March 2024 Upcoming Quarterly Report	View
	14th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Sensei Biotherapeutics Financial Statements

Sensei Biotherapeutics stakeholders use historical fundamental indicators, such as Sensei Biotherapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Sensei Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sensei Biotherapeutics' assets and liabilities are reflected in the revenues and expenses on Sensei Biotherapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sensei Biotherapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	-4 M	-3.8 M
Cost Of Revenue	633.6 K	619.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
V	Visa Class A
MSFT	Microsoft

When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:

How To Invest In Sensei

Details

Is Sensei Stock a good investment?

Details

What is Sensei Biotherapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Sensei Biotherapeutics Correlation against competitors.

For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(19.14)

Return On Assets

(0.37)

Return On Equity

(0.70)

The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Sensei Financial Statements From 2010 to 2026

Sensei Biotherapeutics Balance Sheet

Sensei Biotherapeutics Income Statement

Sensei Biotherapeutics Cash Flow Statement

Financial Ratios

Sensei Biotherapeutics Valuation Data

Sensei Fundamental Market Drivers

Sensei Upcoming Events

About Sensei Biotherapeutics Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY